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Abstract
Alterations in the expression, molecular composition, and localization of voltage-gated sodium channels play
major roles in a broad range of neurological disorders. Recent evidence identifies sodium channel proteolysis
as a key early event after ischemia and traumatic brain injury, further expanding the role of the sodium channel
in neurological diseases. In this study, we investigate the protease responsible for proteolytic cleavage of
voltage-gated sodium channels (NaChs). NaCh proteolysis occurs after protease activation in rat brain
homogenates, pharmacological disruption of ionic homeostasis in cortical cultures, and mechanical injury
using an in vitro model of traumatic brain injury. Proteolysis requires Ca2+ and calpain activation but is not
influenced by caspase-3 or cathepsin inhibition. Proteolysis results in loss of the full-length {alpha}-subunits,
and the creation of fragments comprising all domains of the channel that retain interaction even after
proteolysis. Cell surface biotinylation after mechanical injury indicates that proteolyzed NaChs remain in the
membrane before noticeable evidence of neuronal death, providing a mechanism for altered action potential
initiation, propagation, and downstream signaling events after Ca2+ elevation.
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Brief Communications
Calpain Mediates Proteolysis of the Voltage-Gated Sodium
Channel -Subunit
Catherine R. von Reyn,1 Jennifer M. Spaethling,2Mahlet N. Mesfin,1MarekMa,4,5 Robert W. Neumar,4
Douglas H. Smith,3 Robert Siman,3 and David F. Meaney1,3
Departments of 1Bioengineering, 2Pharmacology, 3Neurosurgery, 4Emergency Medicine, and 5Neuroscience, University of Pennsylvania, Philadelphia,
Pennsylvania 19104
Alterations in the expression, molecular composition, and localization of voltage-gated sodium channels play major roles in a broad
range of neurological disorders. Recent evidence identifies sodium channel proteolysis as a key early event after ischemia and traumatic
brain injury, further expanding the role of the sodium channel in neurological diseases. In this study, we investigate the protease
responsible for proteolytic cleavage of voltage-gated sodium channels (NaChs). NaCh proteolysis occurs after protease activation in rat
brain homogenates, pharmacological disruption of ionic homeostasis in cortical cultures, andmechanical injury using an in vitromodel
of traumatic brain injury. Proteolysis requires Ca2 and calpain activation but is not influenced by caspase-3 or cathepsin inhibition.
Proteolysis results in loss of the full-length -subunits, and the creation of fragments comprising all domains of the channel that retain
interaction even after proteolysis. Cell surface biotinylation after mechanical injury indicates that proteolyzed NaChs remain in the
membrane before noticeable evidence of neuronal death, providing amechanism for altered action potential initiation, propagation, and
downstream signaling events after Ca2 elevation.
Introduction
Serving an integral role in neurotransmission, it is not surprising
that voltage-gated sodium channels (NaChs) underlie or partic-
ipate in a broad array of neurological disorders brought about by
genetic mutations within channel subunits or alterations in sub-
unit expression levels [for a recent review, see Waxman (2007)].
NaChs also playmajor pathophysiological roles in the early stages
of ischemia, spinal cord injury, and traumatic brain injury where
their inhibition preserves electrophysiological properties, leads
to tissue sparing, and promotes functional recovery (Stys et al.,
1992; Agrawal and Fehlings, 1996).
Despite this growing knowledge onNaChs and neurological dis-
ease, less well known is how an active intracellular event—NaCh
proteolysis—contributes to either the incidence or progression
of disease or injury in the nervous system. Overexpression of
-amyloid cleaving enzyme (BACE1) and -secretases leads to
cleavage of the internal domain of the NaCh 2 subunit (Kim et
al., 2005), while axonal stretch injury, ischemic injury to the iso-
lated spinal cord, and pharmacological increases in membrane
permeability lead to proteolysis of the pore forming -subunit of
the channel (Paillart et al., 1996; Iwata et al., 2004; Jette et al.,
2006). However, the site of -subunit proteolysis, the protease
responsible for this cleavage, and the downstream consequences
of proteolysis are not well defined. Here, we investigate NaCh
proteolysis using models mimicking pathological elevations in
cytosolic calcium or, alternatively, traumatic mechanical in-
jury. We show that activated calpain causes NaCh proteolysis,
suggesting that calpain-mediated NaCh cleavage may play an
important pathophysiological role in recovery or demise after
injury.
Materials andMethods
Calpain and caspase-3 activation in rat brain homogenates. All reagents
were purchased fromSigma-Aldrich unless noted otherwise. Brains from
anesthetized adult female CDIGS rats (Charles River Laboratories) were
removed and homogenized in 10 ml of homogenization buffer [10 mM
HEPES, 5 mM EDTA, 0.035% -mercaptoethanol, 0.5 mM phenylmeth-
ylsulphonyl fluoride (PMSF), and 1 M pepstatin A, pH 7.4]. Homoge-
nates were centrifuged (1000  g, 10 min, 4°C) to remove the nuclear
fraction. Protein concentrations were analyzed using the Bio-Rad Dc
Protein Assay. Homogenates were pretreated with or without inhibitors
to calpain (50 M MDL28170, Calbiochem) or the caspases (30 M
z-VAD-FMK,Calbiochem) for 15min on ice. Calcium (1, 5, 10, or 50mM
CaCl2) or active caspase 3 (20 U/ml, Calbiochem) was added to homog-
enates and samples were incubated either at 24°C for 30 min (calpain
activation) or 37°C for 60 min (caspase 3 activation). Control samples
were incubated on ice. The reaction was stopped after addition of elec-
trophoresis sample buffer and 2.5% -mercaptoethanol.
Calpain activation in rat brainmembrane preparations.Adult rat brains
were removed from anesthetized adult female CDIGS rats (Charles River
Laboratories) and homogenized in 10ml of high sucrose buffer formem-
brane preparation (300 mM sucrose, 10 mM Tris, 2 mM EDTA, 0.5 mM
PMSF, and 1MpepstatinA, pH8.1) and centrifuged for 10min (4000
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g, 4°C). The supernatant was subjected to an additional centrifugation
step (100,000  g, 1 h, 4°C), and the pellet was resuspended in Tris-
acetate buffer (100 mM Tris-acetate, 0.1 mM EGTA, 0.5 mM PMSF, and 1
M pepstatin A, pH 7.4) and centrifuged (16,000  g, 10 min, 4°C).
Supernatant (membrane preparation) protein concentrations were ana-
lyzed using the Bio-Rad Dc Protein Assay. Membrane preparations
were pretreated with or without the calpain inhibitor (100 M
MDL28170, Calbiochem) for 15 min on ice. Calcium (1 mM CaCl2)
and/or calpain 1 (5 and 50 U, Calbiochem) was added to membrane
preparations and samples were incubated for 30 min at room tempera-
ture (24°C). The reaction was stopped after addition of electrophoresis
sample buffer and 2.5% -mercaptoethanol.
Cell culture. Cortical neurons from embryonic day 18 rats were iso-
lated andmaintained as described previously (Geddes-Klein et al., 2006).
For the in vitro stretch injury model, cultures were plated on poly-L-
lysine-coated deformable silicone membranes (Sylgard 184 and 186,
Dow Corning).
Ionomycin application and protease inhibition. At days in vitro (DIV)
18–21, cultures were rinsed and incubated for 15min in a saline solution
(media composition, in mM: 100 NaCl, 5.4 KCl, 2 MgCl2, 1.8 mM CaCl2,
26 NaHCO3, 0.9 NaH2PO4, 10 HEPES, 25 glucose, pH 7.4). Where ap-
plicable, inhibitors of calpain (10 M MDL28170), caspases (3 M
z-VAD-FMK), cathepsins (10M z-Phe-Gly-NHO-Bz, Calbiochem), the
proteasome (1 M lactacystin, Calbiochem), and the lysosome (100 M
chloroquine or 50 mM NH4Cl), as well as a 0.2% dimethyl sulfoxide
(DMSO) control, remained in the media throughout the length of the
experiment. In calcium-free media, CaCl2 was
omitted and 1 mM EDTA was added. Cultures
were incubated for various times (0–60 min)
in an incubator with media containing iono-
mycin (1 M, Invitrogen) and lysed (10 mM
HEPES, 200 mM NaCl, 30 mM EDTA, 0.5%
Triton-X, broad spectrum protease inhibitor
cocktail [Complete Protease Inhibitor (Roche)],
50 mM NaF, 10 mM K4P2O7, 1 mM NaVO4).
Lysates were sonicated and centrifuged (1000
g, 10 min, 4°C) to remove the nuclear fraction
and unlysed material.
Calcium imaging. Increases in intracellular
[Ca 2] were measured by using the ratio-
metric cell permeable, fluorescent Ca 2 in-
dicator, Fura-2 A.M. (Invitrogen). Dissociated
neurons were incubated with Fura-2 A.M. (5
M in 0.1% Pluronic F-127, Invitrogen) for 40
min in saline solution at 37°C and 5% CO2.
Using the same time course from the ionomy-
cin studies (see above), cultures were excited at
340 and 380 nm every two seconds, and the
images of the resulting emission (510 nm) in-
tensities were capturedwith aHamamatsu dig-
ital camera (C4742–98, Universal Imaging)
and analyzed using MetaFlour (Molecular De-
vices). Cell bodies were selected as regions of
interest and the average ratios of the intensities
resulting from the two excitation wavelengths
(340 nm/380 nm) over a 1 min period were
collected. A Student’s t test was used to com-
pare treated and untreated groups at each time
point.
Viral vector generation and transduction. Re-
combinant adeno-associated viral (AAV) vec-
tors were generated by the Vector Core at the
University of Pennsylvania. The human cal-
pastatin gene (clone ID 3878564 from Open
Biosystems) was amplified by PCR using
pCMV-SPORT6-hCAST as a template. The
product of the PCR was cloned into ApaI and
KpnI sites of the p1262 plasmid (designed by
the University of Pennsylvania Vector Core).
The vector coexpressed calpastatin and en-
hanced green fluorescent protein (EGFP) under the control of a cyto-
megalovirus (CMV) promoter by using a cis-acting hydrolase element
(CHYSEL) sequence (AAV2/1.CMV.EGFP-T2A-hCAST). The CHYSEL
sequence allowed bicistronic expression from a single transcript by using
a self-cleaving peptide (Szymczak et al., 2004). Recombinant adeno-
associated viral (AAV) vectors were generated by triple transfection of
293 cells, and purified by cesium chloride gradient sedimentation as
described previously (Fisher et al., 1997). Vector genome titers were
measured by real-time PCR using primer/probe set corresponding to the
polyA region of the vectors. The AAV2/1 vector designed to express
EGFP under the control of a CMV promoter was provided by the Uni-
versity of Pennsylvania Vector Core.
Cortical cultures at DIV 8 were transduced with 1  10 10 genome
copies of AAV 2/1 expressing EGFP, and human calpastatin or EGFP
and transduction efficiency was assessed as described previously
(Bevers et al., 2009). At DIV 19, 76 3% and 76 2% efficiency was
achieved with human calpastatin/EGFP or EGFP, respectively.
Fragment isolation through immunoprecipitation. Six 60 mm corti-
cal culture dishes were treated with or without ionomycin and lysed in
600 l of lysis buffer (in mM: 20 Tris-HCl, 200 NaCl, 1 mM EDTA, pH
7.4, inhibitor cocktail). Lysates were centrifuged (16,000 g, 10 min,
4°C), the supernatants were precleared during a 1 h incubation with
40 l of Protein G Plus Agarose slurry (Pierce) at 4°C, and then incu-
bated with 2 g of Nav1.2 C-terminal antibody or 2 g of mouse IgG
overnight at 4°C on a roller. Protein G slurry (40 l) was added to the
Figure 1. Activation of calpain in rat whole-brain membrane preparations results in NaCh proteolysis. A–F. Representative
Western blots displaying propensity or resistance to loss of full-length and appearance of lower-molecular-weight products
recognized by the pan NaCh (A), Nav1.2 C terminal (B), Nav1.2 I–II loop (C), Nav1.1 C terminal (D), spectrin (E), and actin (F )
antibodies after incubations with Ca 2 (1 mM), calpain, and/or MDL28170 (MDL) for 30 min at room temperature. Overexposed
blots highlight NaCh breakdown fragments (A, C).G, Quantification of the representative blots seen inA. F, Data normalized to the
full-length intensity of the corresponding room temperature control (n 3–4, *p 0.05 from the room temperature control).
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antibody/antigen complex and incubated for 1.5 h at 4°C, flow through
was collected, and samples were eluted with 2 sample buffer plus 2%
-mercaptoethanol for 30min at 37°C. Samples were analyzed viaWest-
ern blot as stated below, except that a polyclonal pan (Alomone Labs,
1:1000) instead of a monoclonal pan (Sigma-Aldrich) antibody was used
in this study to reduce IgG immunoreactivity.
In vitro stretch injury.An in vitro injurymodel, as described previously,
was used to stretch injure DIV 12–16 cortical neurons (Lusardi et al.,
2004). In designated experimental groups, neurons were pretreated with
protease inhibitors 15 min before injury. After stretch injury, cultures
were returned to the incubator for 1 or 6 h (37°C, 5% CO2). All inhibi-
tors remained in the culture media for the duration of the experiment.
For Western blot analysis, the injured and uninjured regions were
separated and lysed in the lysis buffer, sonicated, and centrifuged for
10 min (1000  g, 4°C).
Cell death analysis. For cell death assays, stretch injured cultures
were incubated with the cell permeant nuclear marker Hoechst
33342 (5 g/ml, Invitrogen) and cell impermeant marker ethidium
homodimer-1 (2 M, Invitrogen) for 30 min before the 6 h time point
after injury. Dual images were captured using the appropriate excita-
tion/emission filters (Hoechst: 71000A filter set, Chroma Technol-
ogy; Ethidium homodimer: 41004 filter set, Chroma Technology) and
analyzed using MetaMorph (Molecular Devices). Three separate
fields of view were imaged and analyzed within each injured or unin-
jured culture. Hoechst-positive regions of interest (nuclear region)
were identified and counted from the Hoechst emission image to
attain overall cell numbers. The ethidium homodimer emission im-
age was then overlaid with the Hoechst image, and dual positive cells,
indicating loss of membrane integrity and cell death, were counted
and normalized to the total number of cells (Hoechst positive) in an
image. These ratios were averaged over the three images to give a final
ratio per culture. Statistical significance for the data was determined
by ANOVA ( p  0.05). If the data were found to be significant
through ANOVA, post hoc analysis was conducted using Tukey–
Kramer honestly significant difference (HSD) with p  0.05 being
considered significant.
Biotinylation. Surface proteins from cultures were biotinylated 6 h
after stretch injury using an established procedure (Wu et al., 2007). Cul-
tureswereplacedon ice and incubated inaPBS solutioncontaining1mg/ml
biotin (Sulfo-NHS-Biotin, Pierce), rinsed, and the injured region was
dissected out and lysed in RIPA lysis buffer. Biotinylated proteins were
purified by adhesion to immobilized monomeric avadin (Pierce) while
the unbound lysate was collected as the internal fraction. The biotinyl-
ated, surface proteins were eluted from the beads with electrophoresis
sample buffer with 2% -mercaptoethanol during heating to 37°C for 30
min. Initial lysate, internal, and biotinylated fractions were subjected to
Western blot analysis as mentioned below.
Western blot. Equal protein amounts (10 g) from denatured samples
were run on a 3–8% Tris-acetate gel (Invitrogen), transferred to PVDF
membranes (Bio-Rad), and probed for the NaCh -subunit III–IV loop
(pan: Sigma Aldrich, 1:1000), the Nav1.2 C terminal [University of Cal-
ifornia (UC), Davis/National Institutes of Health (NIH) NeuroMab Fa-
cility, 1:1000], the Nav1.2 I–II loop (Alomone Labs, 1:1000), and the
Nav1.1 C terminal (UC Davis/NIH NeuroMab Facility, 1:500) of the
NaCh. Blots were stripped and reprobed for actin (Millipore Bioscience
Research Reagents, 1:10,000), -spectrin (MAB1622: Millipore Bio-
science Research Reagents, 1:10,000) using an antibody that recognizes
the full-length protein and calpain/caspase 3-specific breakdown products
(Siman et al., 1984), or human calpastatin (Millipore Bioscience Research
Reagents, 1:1000). Blots were incubated with corresponding HRP-
conjugated antibodies (Jackson ImmunoResearch Laboratories). Blots were
quantified using a computer assisted two-dimensional densitometric
scanning program (Kodak 1D Image Analysis Software, Eastman Kodak
Company). All proteinswere normalized to corresponding negative/pos-
itive control groups. Statistical significance was determined by ANOVA
( p  0.05). Post hoc analysis was conducted using Tukey-Kramer HSD
with a p  0.05 being considered significant. Data were plotted as
mean SEM.
Results
Calcium elevation leads to calpain-dependent proteolysis of
the NaCh in rat brain homogenates
To investigate NaCh proteolysis in a simplified system, we incu-
bated adult rat brain homogenates isolated in a 5 mM EDTA
buffer for 30 min with 10mMCa2 at room temperature (24°C).
After Western blot, the -spectrin antibody recognized 150 kDa
bands, a known calpain/caspase 3-mediated breakdown product
(supplemental Fig. S1A,B, available at www.jneurosci.org as sup-
plemental material). Probing for NaChs using a pan antibody
showed a concurrent accumulation of an160 kDa and 110 kDa
fragment and a loss of the full-length channel (supplemental Fig.
S1A,B, available at www.jneurosci.org as supplemental mate-
rial). Pretreatment with the calpain inhibitorMDL28170, but not
the caspase inhibitor z-VAD-FMK, prevented both spectrin and
pan NaCh fragment formation, suggesting that calcium addi-
tion leads to only calpain activation and subsequent proteol-
Figure 2. Overexpression of human calpastatin in rat cortical cultures prevents ionomycin-induced NaCh proteolysis. A, Representative Western blots showing the effect of calpastatin on NaCh
proteolysis. At DIV 19, 10 d after transduction using anAAVwith EGFP alone or EGFP andhuman calpastatin, cortical cultureswere incubatedwith ionomycin (1M) for 1 h. Cultures transducedwith
calpastatin/EGFP displayed no significant ionomycin-inducedNaCh-subunit (pan, Nav1.2 C terminal) or spectrin proteolysis comparedwith those transducedwith EGFP alone.B, Quantification of
the representative blots seen in A. Data normalized to the corresponding untreated EGFP control (n 4, *p 0.05 from the EGFP control).
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ysis of both proteins (supplemental Fig. S1A,B, available at
www.jneurosci.org as supplemental material). To further vali-
date that NaCh proteolysis is calpain specific, active caspase 3 was
added to rat brain homogenates at 37°C for 1 h. The 150 kDa
spectrin breakdown product appeared and was prevented during
pretreatment with the caspase inhibitor, while no proteolysis of
theNaChwasobserved (supplemental Fig. S1A,B, available atwww.
jneurosci.org as supplementalmaterial). Therefore, NaChproteoly-
sis appears to be specific to calpain activation in this model.
Calpain cleaves multiple NaCh
-subunits in membrane preparations
The NaCh isoform targeted by calpain-mediated proteolysis
was investigated further in isolated whole rat brain membranes.
Calpain 1 and 1 mM Ca2 were added to preparations and incu-
bated for 30 min at room temperature. The addition of 1 mM
Ca2 alone was enough to induce fragment formation recog-
nized by the NaCh pan, Nav1.2 (I–II loop), and spectrin antibod-
ies. Adding calpain produced 160 and 110 kDaNaCh bands (pan,
Nav1.2 C terminal) or 150, 100, and 80 kDa bands (Nav1.2 I–II
loop) as well as the 150 kDa spectrin band (Fig. 1A–G). A signif-
icant loss of full-length protein immunoreactivity occurred for all
proteins after 50 U calpain addition, while 5 U was enough to
produce significant loss as recognized by the panNaCh antibody.
For Nav1.1 (C terminal), no increase in fragment accumulation
occurred, even after a significant decrease
in the full-length band, suggesting a loss in
immunoreactivity after proteolysis. This
indicates that the NaCh -subunit is
highly susceptible to calpain-mediated
proteolysis, but that proteolysismay differ
among -subunits.
Calpain-mediated proteolysis of the
NaCh in dissociated cortical cultures
occurs after elevating intracellular Ca2
We next determined whether Ca2/
calpain-dependent proteolysis occurs in
cortical neurons. Treating cortical neu-
rons with a calcium ionophore (1 M
ionomycin) allowed us to gradually ele-
vate the intracellular [Ca2] over 1 h
(supplemental Fig. S2, available at www.
jneurosci.org as supplemental material).
Immunoblotting showed 150 kDa spec-
trin breakdown products, increasing in
density with the time of ionomycin appli-
cation, indicative of either calpain or
caspase 3 activation (supplemental Fig.
S3A,B, available at www.jneurosci.org as
supplemental material). Over this time
course, the160 and 110 kDa proteolytic
fragments appeared concurrently, as rec-
ognized by the pan NaCh antibody. Re-
moving Ca2 from the bathing solution
and adding 1 mM EDTA (supplemental
Fig. S3D,F, available at www.jneurosci.
org as supplemental material) eliminated
spectrin and NaCh breakdown.
Cortical neurons were then treated for
15 min with inhibitors targeting calpain I
and II (MDL28170), caspases (z-VAD-
FMK), cathepsins B, L, and S (z-Phe-
Gly-NHO-Bz), the lysosome (chloroquine or NH4Cl), or the
proteasome (lactacystin) before ionomycin application (supple-
mental Fig. S3C,E,F, available at www.jneurosci.org as supple-
mentalmaterial).Only the calpain inhibitor significantly reduced
the density of the ionomycin-mediatedNaCh and spectrin break-
down products to the level of the sham cultures. Lysosomal inhi-
bition with chloroquine caused a small, yet significant, reduction
in NaCh fragment formation. However, pretreatment with a sec-
ond lysosome inhibitor (NH4Cl) or the cathepsin inhibitor had
no significant effect on proteolysis (supplemental Fig. S3C,E,F,
available at www.jneurosci.org as supplemental material), sug-
gesting that the proteolytic protection provided by MDL28170
was primarily derived from its inhibition of calpain and not other
proteases contained in the lysosome (Bevers and Neumar, 2008).
Thus far, the only highly specific inhibitor of calpain 1 and 2 is
their endogenous inhibitor, calpastatin (Bevers and Neumar,
2008). To further validate that proteolysis was calpain specific, we
overexpressed human calpastatin and EGFP in our rat neuronal
cultures, transducing EGFP alone as a control. At DIV 19, 12 d
after transduction, no significant loss of full-length NaChs or
spectrin was observed in cultures overexpressing calpastatin after
a 1 h ionomycin treatment, while significant loss was seen in all
cultures only expressing EGFP (Fig. 2). This further supports the
calpain specificity of NaCh proteolysis in cortical cultures after
Ca2 elevation.
Figure 3. Calpain-mediated NaCh proteolysis results in cleavage at two sites along Nav1.2. A, The Nav1.2 channel was immu-
noprecipitated from ionomycin-treated (Io; 1M, 1 h) or control cultures using the Nav1.2 C-terminal antibody and probed for
using a pan NaCh (III–IV loop) and Nav1.2 (I–II loop) antibody. In ionomycin-treated cultures, the pan antibody recognized the
immunoprecipitated full-length channel and the 160 and 110 kDa fragmentswhile theNav1.2 (I–II loop) antibody displayed a loss
of immunoreactivity for the 150, 100, and 80 kDa fragments. No immunoreactivitywas seen inmouse IgG-treated lysates (n 3).
B, Cleavage sites and corresponding fragment creation within Nav1.2, as recognized by domain-specific antibodies and immuno-
precipitation. Estimated cleavage sites are within the II–III loop and I–II loop. Sites of glycosylation (G), phosphorylation (P),
ankyrin G binding (Ank G), and endocytosis (E) are indicated on the figure.
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Nav1.2 fragment analysis suggests
either 2 or 3 cleavage sites exist along
the channel
As shown in the previous studies, both the
pan NaCh antibody as well as the Nav1.2
(C-terminal) antibody recognize 160 and
110 kDa fragments, while the Nav1.2 (I–II
loop) antibody recognizes 150, 100, and
80 kDa fragments. We hypothesized that
the pan andNav1.2 C-terminal antibodies
were recognizing the same fragments, and
therefore fragments immunoprecipitated
by one antibody would be recognized by
the other. Pulling down with the Nav1.2
(C-terminal) antibody and probing with
the pan (III–IV loop) antibody displayed
an enrichment in immunoreactivity for
the full-length, 160, and 110 kDa bands,
compared with the original lysate, indi-
cating that the antibodies are indeed rec-
ognizing the same parts of the channel
(Fig. 3A). The fragments recognized by
the Nav1.2 I–II loop antibody are theoret-
ically too small to contain the C terminal,
and we expected to see a loss of fragment
immunoreactivity during probing for
Nav1.2 I–II after pulling down with the
Nav1.2 C-terminal antibody. Indeed,
while enrichment of immunoreactivity for
the full-length Nav1.2 still occurred, im-
munoreactivity for all I–II loop contain-
ing fragments decreased, compared with
the original lysate, suggesting a loss of di-
rect binding to the Nav1.2 C-terminal an-
tibody. The small amount of I–II loop
containing fragments in the elution sug-
gests that even after proteolysis, the do-
mains of Nav1.2 retain their association in
the membrane. Figure 3B summarizes
these findings, displaying estimated cleav-
age sites withinNav1.2. The first predicted
site occurs within the I–II loop, resulting
in a 160 kDa fragment (containing the
III–IV loop and C-terminal) and a 100
kDa fragment (containing the I–II loop).
The second predicted site occurs within
the II–III loop, resulting in a 110 kDa frag-
ment (containing the III–IV loop and C
terminal) and a 150 kDa fragment (con-
taining the I–II loop). The origin of the
final fragment (80 kDa, I–II loop) is less clear in this model. One
possibility is that it indicates a third cleavage site within the N
terminal or the I–II loop, creating a shortened version of the 100
kDa fragment containing domain I. However, nonspecific recog-
nition of different NaCh isoform fragments cannot be ruled out,
since a corresponding 180 kDa fragment recognized by the
Nav1.2 C terminal antibody does not appear on these blots.
Proteolysis of the NaCh in an in vitromodel of traumatic
brain injury
Next, we investigated NaCh proteolysis in an in vitro model of
traumatic brain injury that produces little immediate change in
membrane permeability, but rather causes the activation of neuro-
nal receptors and channels that include the NMDA receptor
(Geddes-Klein et al., 2006). We used a level of stretch causing no
significant increase in neuronal death 6 h after injury (supple-
mental Fig. S4, available at www.jneurosci.org as supplemental
material), yet causing significant neuronal death 24 h after injury
(Spaethling et al., 2008). Subsequently, we injured at these strain
levels (60–80%) and collected lysates at 1 and 6 h time points.
The pan NaCh antibody was chosen in these studies for robust
recognition of fragment formation and channel loss. No signifi-
cant accumulation of NaCh fragments appeared 1 h after injury
(data not shown), yet a significant increase in both -spectrin
(150 kDa) and NaCh fragments (110 kDa) over uninjured con-
trols was seen 6 h after mechanical injury (Fig. 4A,B). Consistent
Figure 4. Calpain-dependent NaCh proteolysis occurs in an in vitromodel of cortical stretch injury, targeting a specific internal
loop of the channel. A, Representative Western blots displaying NaCh proteolysis after a 60–80% stretch injury, with or without
pretreatmentwith the calpain inhibitor (MDL28170;MDL).B, Quantification of the representative blots seen inA.Data normalized
to the corresponding stretch injured culture (n 4, *p 0.05 from the uninjured control). C, Representative Western blot
showing the cellular distribution of proteolyzed NaChs after stretch injury. Six hours after injury, surface membrane biotinylation
wasperformedon cultureswith orwithout a 15minMDL28170pretreatment. The110and80kDaNaCh fragments appeared in the
surface fraction, as recognizedby thepanandNav1.2 (I–II loop) antibody, respectively, suggesting thatbothaC- andanN-terminal
portion of the channel remain in the membrane after proteolysis (n 4).
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with previous data,mechanically injured cultures pretreatedwith
the calpain inhibitor displayed a reduction in spectrin and NaCh
-subunit fragment accumulation (Fig. 4A,B).
A portion of cleaved NaChs remain at the membrane surface
To investigate cellular locations of proteolyzed sodium channels
accumulating 6 h after stretch injury, biotinylated neuronal sur-
face proteins were probed with the pan (III–IV loop) and Nav1.2
(I–II loop) antibodies, alongwith actin as a control for evaluating
the purity of the fractions. Both 110 kDa III–IV loop containing
fragments and 80 kDa I–II loop containing fragments were iden-
tified in the biotinylated, surface fraction, indicating that thema-
jority of the channel remains at the surface after proteolysis (Fig.
4C). Fragments were also identified in the internal fraction, indi-
cating that either proteolyzed channels eventually become inter-
nalized, or that calpain-mediated proteolysis is not specific to
surfaceNaChs and also targets those located in the intracellular
pool (Schmidt et al., 1985). Pretreatment of cultures with the
calpain inhibitor resulted in a reduction of accumulation in
the biotinylated fraction. These data indicate that calpain-
mediated proteolysis of the channel does not lead to immedi-
ate internalization.
Discussion
In this study, we find that NaCh proteolysis occurs consistently
after three experimentalmanipulations—activating calpain in rat
brain preparations, after application of the Ca2 ionophore
ionomycin to elevate cytosolicCa2 in cortical neurons, and after
mechanical stretch injury to cortical neurons. All conditions lead
to robust calpain activation, as seen from the formation of
calpain-specific spectrin breakdown products. Blocking calpain
pharmacologically or through overexpression of its endogenous
inhibitor calpastatin prevents both NaCh and spectrin proteoly-
sis, while blocking other cysteine proteases including the caspases
and cathepsin B, L, and S, as well as normal protein turnover
mechanisms of the lysosome and proteasome, does not reduce
proteolysis to control levels. At least two sites of proteolysis exist,
within the I–II and II–III loops of Nav1.2, and some degree of
association remains between fragments after proteolysis. In
stretch injured cultures, surface biotinylation identifies frag-
ments comprising both the C- and N-terminal parts of Nav1.2,
indicating that proteolyzed channels remain in the membrane
after cleavage.
Proteolysis of NaCh -subunits appears after ischemic injury
to the isolated spinal cord, after elevation of intracellular Na
in cultured neurons, and after mechanical injury to cultured
axons (Paillart et al., 1996; Iwata et al., 2004; Jette et al., 2006).
Unlike the highly Na-dependent removal of NaChs from the
surface preceding degradation in the lysosome (Paillart et al.,
1996), our data demonstrates a primarily calpain-mediated/
Ca2-dependent proteolysis. In addition, our proteolysis re-
quires more time than the relatively rapid (20 min) loss of the
immunoreactivity to theNaCh inactivation loop observed in cul-
tured axons after mechanical injury. However, calpain is one
protease family targeted by the broad spectrum protease inhibi-
tion technique used by Iwata et al. (2004), pointing out the pos-
sibility that calpain may also play a role with channel proteolysis
in cultured axons.
Based on fragment formation/migration using several-subunit
antibodies, our data indicates that proteolysis occurs within the
I–II and II–III loop of Nav1.2, providing several possible roles in
which the calpain-mediated process may affect neurological
function. Proteolysis within the II–III linker could interfere with
cytoskeletal anchoring through ankyrin-G and spectrin (Jenkins
and Bennett 2001) or endocytosis by affecting the internalization
sequence found within this loop (Fache et al., 2004). The I–II
loop contains multiple phosphorylation sites, and proteolysis
along this region could alter kinase- and phosphatase-mediated
channel regulation (Cantrell and Catterall, 2001; Beacham et al.,
2007). Within Nav1.1, proteolysis resulted in loss of immunore-
activity for the C terminal without fragment formation, indicat-
ing that sites of proteolysis may differ between -subunits.
Perhaps the most intriguing is our finding that proteolysis
occurs before the loss of membrane integrity, a hallmark end
stage indicator of neuronal death. In combination with our find-
ing that proteolyzed NaChs remain at the surface, this suggests
that proteolyzed NaChs can contribute to the complex cascades
triggered by cytosolic calcium elevations and subsequent calpain
activation. Calpain activation occurs in axons and neuronal so-
mata throughout the brain after traumatic brain and spinal cord
injury, stroke, and within a large number of degenerative neuro-
logical diseases (Saatman et al., 1996; Siman et al., 1996; Bu¨ki et
al., 1999; Ray et al., 2003; Vosler et al., 2008). Future work on the
calpain-mediated proteolysis of NaChs will determine whether
this proteolytic event is evidence of a clear commitment to de-
generation or, alternatively, a step that could be used ultimately
as a survival signal. Once the implications ofNaChproteolysis are
better understood, one can examine the potential benefits of
calpain-specific therapies already available and ready for preclin-
ical testing.
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